Fundraising FoxAvails Medical
Menlo Park, US · Founded 2013 · Delaware corporation · 2 known investors
Find your way into Avails Medical
1,033 people in our graph share verified history with the Avails Medical team — schools, employers, funds. One of them is your warm intro.
Uri Lopatinunlockedknows Oren Knopfmacher · together at StartX Med (overlapped)
knows the team · via StartX Med
×10knows the team · via StartX
Avails Medical develops the eQUANT™ System, an FDA-cleared diagnostic platform using electronic biosensor technology for rapid antimicrobial susceptibility testing in infectious disease care. The system targets hospitals and clinical laboratories to accelerate diagnosis of infections like sepsis and combat antimicrobial resistance.
Founders & leadership
Avails Medical was founded in 2013 by Oren Knopfmacher.
OK
Oren KnopfmacherFounderOren Knopfmacher holds a PhD in Experimental Physics and conducted postdoctoral research in biosensors at Stanford University before co-founding Avails Medical in 2014, which he leads as CEO and director; he has authored over 60 patents in diagnostic technology.
Board
ML
Michael LauferBoard director
NI
Nancy IsaacBoard director
Investors · 2
Omron VenturesreportedKyoto
How we know: funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements$10.4M disclosed across 5 rounds · 2014–2022
- $1.7MraisedSep 2022 · 2 sourcesSource ↗
▶$6.4MraisedFeb 2017 · 41 investors · Other Health CareRule 506(b)
▶$6.4MraisedFeb 2017 · 41 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael LauferDirector
- Aaron BerezDirector
- Nancy IsaacDirector
- Oren KnopfmacherExecutive Officer, Director
- Offering amount
- $10.9M
- Amount sold
- $6.4M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$500KraisedJul 2016 · 1 investors · Other Health CareRule 506(b)
▶$500KraisedJul 2016 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael LauferDirector
- Oren KnopfmacherExecutive Officer, Director
- Nancy IsaacDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$550KraisedMar 2016 · 3 investors · Other Health CareRule 506(b)
▶$550KraisedMar 2016 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael LauferDirector
- Nancy IsaacDirector
- Oren KnopfmacherExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $550K
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.3MraisedDec 2014 · 18 investors · Other Health CareRule 506(b)
▶$1.3MraisedDec 2014 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Oren KnopfmacherExecutive Officer, Director
- Nancy IsaacDirector
- Michael LauferDirector
- Offering amount
- $1.8M
- Amount sold
- $1.3M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
IQVIA7 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
LeadIQ7 shared keywordsLeadIQ offers a company search tool that provides B2B company profiles with data such as revenue, employee count, funding, and contact information to help sales teams find decision makers and build pipeline.
Fortis Life Sciences4 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
Agilent4 shared keywordsAgilent manufactures laboratory instruments, software, reagents, and consumables for pharmaceutical, diagnostics, clinical research, and applied markets including chemicals, food, and environmental sectors. The company operates through three segments: Life Sciences and Diagnostics Markets (which includes contract manufacturing services for oligonucleotide therapeutics and pathology solutions), Agilent CrossLab (providing lab services and automation), and Applied Markets (offering analytical instruments and software).
Companies competing with Avails Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Avails Medical do?
- Avails Medical develops the eQUANT™ System, an FDA-cleared diagnostic platform using electronic biosensor technology for rapid antimicrobial susceptibility testing in infectious disease care. The system targets hospitals and clinical laboratories to accelerate diagnosis of infections like sepsis and combat antimicrobial resistance.
- Who founded Avails Medical?
- Avails Medical was founded by Oren Knopfmacher in 2013.
- Who are Avails Medical's investors?
- Avails Medical's investors include Astia, Omron Ventures.
- How much funding has Avails Medical raised?
- Avails Medical has disclosed $10.4M raised across 5 rounds.
- Where is Avails Medical headquartered?
- Avails Medical is headquartered in Menlo Park, US.